Adenosine A 2B receptor blockade slows growth of bladder and breast tumors

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 198-205

  Cekic, Caglar ^a   Sag, Duygu ^a   Li, Yuesheng ^b   Theodorescu, Dan ^c   Strieter, Robert M ^b   Linden, Joel ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2B RECEPTOR; AMINOPHYLLINE; ATL 801; CD11B ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; N [5 (1 CYCLOPROPYL 2,6 DIOXO 3 PROPYL 2,3,6,7 TETRAHYDRO 1H PURIN 8 YL)PYRIDINE 2 YL] N ETHYL 6 NICOTINAMIDE; UNCLASSIFIED DRUG; CD86 PROTEIN, MOUSE; CXCL10 PROTEIN, MOUSE; CXCR3 PROTEIN, MOUSE; HOMEODOMAIN PROTEIN; RAG 1 PROTEIN; RAG-1 PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER TUMOR; BONE MARROW CELL; BREAST TUMOR; CANCER INHIBITION; CONTROLLED STUDY; ENDOTHELIAL CELL PRECURSOR; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE ACTIVATION; TUMOR ASSOCIATED LEUKOCYTE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; CANCER TRANSPLANTATION; DENDRITIC CELL; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; HISTOCOMPATIBILITY; IMMUNOLOGY; ISOGRAFT; METABOLISM; MOUSE MUTANT; PATHOLOGY; TUMOR CELL LINE;

ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; ANTIGENS, CD86; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL LINE, TUMOR; CHEMOKINE CXCL10; DENDRITIC CELLS; FEMALE; HOMEODOMAIN PROTEINS; INTERFERON-GAMMA; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; NEOPLASM TRANSPLANTATION; RECEPTOR, ADENOSINE A2B; RECEPTORS, CXCR3; TRANSPLANTATION CHIMERA; TRANSPLANTATION, ISOGENEIC; URINARY BLADDER NEOPLASMS;

EID: 84855408091     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101845     Document Type: Article

References (33)

1. Lukashev, D., A. Ohta, and M. Sitkovsky. 2007. Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer Metastasis Rev. 26: 273-279. (Pubitemid 47101659)
2. Clayton, A., S. Al-Taei, J. Webber, M. D. Mason, and Z. Tabi. 2011. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production. J. Immunol. In press.
3. Gessi, S., S. Merighi, V. Sacchetto, C. Simioni, and P. A. Borea. 2011. Adenosine receptors and cancer. Biochim. Biophys. Acta. 1808: 1400-1412.
4. Stagg, J., and M. J. Smyth. 2010. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 29: 5346-5358.
5. Stagg, J., U. Divisekera, N. McLaughlin, J. Sharkey, S. Pommey, D. Denoyer, K. M. Dwyer, and M. J. Smyth. 2010. Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis. Proc. Natl. Acad. Sci. USA 107: 1547-1552.
6. Ohta, A., E. Gorelik, S. J. Prasad, F. Ronchese, D. Lukashev, M. K. Wong, X. Huang, S. Caldwell, K. Liu, P. Smith, et al. 2006. A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl. Acad. Sci. USA 103: 13132-13137. (Pubitemid 44338928)
7. Ryzhov, S., S. V. Novitskiy, R. Zaynagetdinov, A. E. Goldstein, D. P. Carbone, I. Biaggioni, M. M. Dikov, and I. Feoktistov. 2008. Host A(2B) adenosine receptors promote carcinoma growth. Neoplasia 10: 987-995.
8. Merighi, S., C. Simioni, S. Gessi, K. Varani, P. Mirandola, M. A. Tabrizi, P. G. Baraldi, and P. A. Borea. 2009. A(2B) and A(3) adenosine receptors modulate vascular endothelial growth factor and interleukin-8 expression in human melanoma cells treated with etoposide and doxorubicin. Neoplasia 11: 1064-1073.
9. Dubey, R. K., D. G. Gillespie, and E. K. Jackson. 2002. A(2B) adenosine receptors stimulate growth of porcine and rat arterial endothelial cells. Hypertension 39: 530-535. (Pubitemid 34165178)
10. Nuhoglu, Y., and C. Nuhoglu. 2008. Aminophylline for treating asthma and chronic obstructive pulmonary disease. Expert Rev. Respir. Med. 2: 305-313. (Pubitemid 351959389)
11. Hochwald, C., K. Kennedy, J. Chang, and F. Moya. 2002. A randomized, controlled, double-blind trial comparing two loading doses of aminophylline. J. Perinatol. 22: 275-278. (Pubitemid 34619098)
12. Linden, J., T. Thai, H. Figler, X. Jin, and A. S. Robeva. 1999. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells. Mol. Pharmacol. 56: 705-713. (Pubitemid 29491171)
13. Strieter, R. M., M. D. Burdick, J. Mestas, B. Gomperts, M. P. Keane, and J. A. Belperio. 2006. Cancer CXC chemokine networks and tumour angiogenesis. Eur. J. Cancer 42: 768-778.
14. Tao, K., M. Fang, J. Alroy, and G. G. Sahagian. 2008. Imagable 4T1 model for the study of late stage breast cancer. BMC Cancer 8: 228.
15. Kolachala, V., B. Ruble, M. Vijay-Kumar, L. Wang, S. Mwangi, H. Figler, R. Figler, S. Srinivasan, A. Gewirtz, J. Linden, et al. 2008. Blockade of adenosine A2B receptors ameliorates murine colitis. Br. J. Pharmacol. 155: 127-137.
16. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
17. Novitskiy, S. V., S. Ryzhov, R. Zaynagetdinov, A. E. Goldstein, Y. Huang, O. Y. Tikhomirov, M. R. Blackburn, I. Biaggioni, D. P. Carbone, I. Feoktistov, and M. M. Dikov. 2008. Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112: 1822-1831.
18. Wilson, J. M., W. G. Ross, O. N. Agbai, R. Frazier, R. A. Figler, J. Rieger, J. Linden, and P. B. Ernst. 2009. The A2B adenosine receptor impairs the maturation and immunogenicity of dendritic cells. J. Immunol. 182: 4616-4623.
19. Iyoda, T., S. Shimoyama, K. Liu, Y. Omatsu, Y. Akiyama, Y. Maeda, K. Takahara, R. M. Steinman, and K. Inaba. 2002. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195: 1289-1302. (Pubitemid 34564331)
20. Strieter, R. M., M. D. Burdick, B. N. Gomperts, J. A. Belperio, and M. P. Keane. 2005. CXC chemokines in angiogenesis. Cytokine Growth Factor Rev. 16: 593-609. (Pubitemid 41505519)
21. Bodnar, R. J., C. C. Yates, M. E. Rodgers, X. Du, and A. Wells. 2009. IP-10 induces dissociation of newly formed blood vessels. J. Cell Sci. 122: 2064-2077.
22. Campanella, G. S., R. A. Colvin, and A. D. Luster. 2010. CXCL10 can inhibit endothelial cell proliferation independently of CXCR3. PLoS ONE 5: e12700.
23. Spychala, J. 2000. Tumor-promoting functions of adenosine. Pharmacol. Ther. 87: 161-173.
24. Kong, T., K. A. Westerman, M. Faigle, H. K. Eltzschig, and S. P. Colgan. 2006. HIF-dependent induction of adenosine A2B receptor in hypoxia. FASEB J. 20: 2242-2250. (Pubitemid 44953854)
25. Yang, M., C. Ma, S. Liu, Q. Shao, W. Gao, B. Song, J. Sun, Q. Xie, Y. Zhang, A. Feng, et al. 2010. HIF-dependent induction of adenosine receptor A2b skews human dendritic cells to a Th2-stimulating phenotype under hypoxia. Immunol. Cell Biol. 88: 165-171.
26. Doedens, A. L., C. Stockmann, M. P. Rubinstein, D. Liao, N. Zhang, D. G. DeNardo, L. M. Coussens, M. Karin, A. W. Goldrath, and R. S. Johnson. 2010. Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res. 70: 7465-7475.
27. Chen, H., D. Yang, S. H. Carroll, H. K. Eltzschig, and K. Ravid. 2009. Activation of the macrophage A2b adenosine receptor regulates tumor necrosis factor-alpha levels following vascular injury. Exp. Hematol. 37: 533-538.
28. Weinberger, M., and L. Hendeles. 1996. Theophylline in asthma. N. Engl. J. Med. 334: 1380-1388. (Pubitemid 26152719)
29. Yasui, K., Y. Kondo, T. Wada, M. Yashiro, M. Tsuge, and T. Morishima. 2009. Theophylline inhibits the differentiation of human monocyte into dendritic cell potentially via adenosine receptor antagonism. Clin. Exp. Allergy 39: 1857-1865.
30. Lentini, A., F. Vidal-Vanaclocha, F. Facchiano, M. Caraglia, A. Abbruzzese, and S. Beninati. 2000. Theophylline administration markedly reduces hepatic and pulmonary implantation of B16-F10 melanoma cells in mice. Melanoma Res. 10: 435-443.
31. Menon, L. G., A. D. Ingle, and R. P. Gude. 2002. Tumor regression of B16F10 melanoma in vivo by prevention of neovascularization: study on theophylline. Cancer Biother. Radiopharm. 17: 213-217. (Pubitemid 34507421)
32. Andersson, A., S. C. Yang, M. Huang, L. Zhu, U. K. Kar, R. K. Batra, D. Elashoff, R. M. Strieter, S. M. Dubinett, and S. Sharma. 2009. IL-7 promotes CXCR3 ligand-dependent T cell antitumor reactivity in lung cancer. J. Immunol. 182: 6951-6958.
33. Andersson, A., M. K. Srivastava, M. Harris-White, M. Huang, L. Zhu, D. Elashoff, R. M. Strieter, S. M. Dubinett, and S. Sharma. 2011. Role of CXCR3 ligands in IL-7/IL-7R{alpha}-Fc-mediated antitumor activity in lung cancer. Clin. Cancer Res. 17: 3660-3672.